Physiological melanin hyperpigmentation is the result of increased melanin biosynthesis by melanocytes in the basal cell layer of the oral epithelium, but pathological melanin pigmentation may be the result of increased number of normal melanocytes or atypical melanocytes, of increased melanogenic activity of normal or atypical melanocytes, or of both
What it means for GLP-1 marketers: Microdosing signals an emerging trend in the GLP-1 market focused on maintenance and metabolic health
The latter is supported by our evaluation of the sequences that revealed no mismatches in the probe target region for the subtypes confirmed by sequencing while there were mismatches observed for the other subtypes, respectively
Before your first fill, it's worth asking three questions: Which GLP-1 does your plan favor
Cignas typical PA requirements for Wegovy include: BMI documentation Documented BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea Comorbidity documentation If your BMI is between 27 and 30, your clinician must provide clinical evidence of at least one qualifying comorbidity and explain why weight reduction would improve that condition Clinical evaluation Documentation of a thorough clinical evaluation, including weight history, prior weight management attempts, and current health status Prescriber qualifications The prescriber must have appropriate authority and, in some plans, must be a specialist or part of a weight management program Prior authorization is a documentation requirement, not a denial
